Skip to content
  • Brazil
  • Canada
  • Europe
  • India
  • Italy
  • Japan
  • Korea
  • Latam
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • Language
  • +91 11 4925 6000
  • Request information
  • +91 11 4925 6000
  • Part of brands: |
IndiaIndia
  • Part of brands: |
  • We guide you
    • Fertility
    • Inherited diseases
    • Worry-free pregnancy
  • Reproductive Health
    • Specialists
      • SAT
      • CGT
      • PGT-A
      • PGT-M
      • PGS+ERA Synchrony
      • Embrace
      • ERA
      • EMMA
      • ALICE
      • Endometrio
      • Family POC
    • Patients
      • SAT
      • CGT
      • PGT-A
      • PGT-M
      • PGS + ERA Synchrony
      • Embrace
      • ERA
      • EMMA
      • Family POC
      • ALICE
      • Endometrio
  • Diagnostic
  • About us
    • Igenomix Research
    • About Igenomix
  • ACADEMY
Genomics Precision Diagnostic > Dermatology Precision Panel > Oculocutaneous Albinism Precision Panel

Oculocutaneous Albinism Precision Panel

Albinism is a group of inherited abnormalities of melanin synthesis and are characterized by a decrease or absence of melanin pigment. There are several types of albinism, one of them being oculocutaneous albinism (OCA). 
Overview
Indication
Clinical Utility
Genes & Diseases
Methodology
References

Overview

  • Albinism is a group of inherited abnormalities of melanin synthesis and are characterized by a decrease or absence of melanin pigment. There are several types of albinism, one of them being oculocutaneous albinism (OCA). OCA is an autosomal recessive disease of melanin biosynthesis which leads to complete or partial loss of melanin in the skin, hair follicles and eyes. This is due to mutations in genes encoding for enzymes responsible for melanin synthesis. The clinical symptoms and the course of the disease show a pronounced variability, this is due to different gene mutations affecting various points along the melanin pathway. Some of the manifestations include nystagmus, iris hypopigmentation and translucency, reduced pigmentation of the retina, reduced visual acuity etc. They are prone to deleterious effects of ultraviolet light, and therefore increased susceptibility to develop actinic keratosis, squamous cell carcinoma and basal cell carcinoma.  
  • The Igenomix Oculocutaneous Albinism Precision Panel can be used to make an accurate and directed diagnosis ultimately leading to a better management and prognosis of the disease. It provides a comprehensive analysis of the genes involved in this disease using next-generation sequencing (NGS) to fully understand the spectrum of relevant genes involved.

Indication

  • The Igenomix Oculocutaneous Albinism Precision Panel is indicated for those patients with a clinical suspicion or diagnosis with or without the following manifestations: 
    • Pinkish-coloured skin 
    • Blue-gray irides 
    • White hair 
    • Prominent red reflex 
    • Poor visual acuity 
    • Photophobia 
    • Nystagmus 
    • Foveal hypoplasia 

Clinical Utility

The clinical utility of this panel is: 

  • The genetic and molecular confirmation for an accurate clinical diagnosis of a symptomatic patient. Patient education on preventive sun exposure measures.    
  • Early initiation of protection from sunlight in form of sunscreen and sun-avoidance methods. Surveillance for early detection of neoplasms and ophthalmology consultations. 
  • Risk assessment and genetic counselling of asymptomatic family members according to the mode of inheritance.

Genes & Diseases

Methodology

References

See scientific referrals

Kubasch, A. S., & Meurer, M. (2017). Okulokutaner und okulärer Albinismus [Oculocutaneous and ocular albinism]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 68(11), 867–875. https://doi.org/10.1007/s00105-017-4061-x 

Grønskov, K., Ek, J., & Brondum-Nielsen, K. (2007). Oculocutaneous albinism. Orphanet journal of rare diseases, 2, 43. https://doi.org/10.1186/1750-1172-2-43 

Kamaraj, B., & Purohit, R. (2014). Mutational analysis of oculocutaneous albinism: a compact review. BioMed research international, 2014, 905472. https://doi.org/10.1155/2014/905472 

Yang, Q., Yi, S., Li, M., Xie, B., Luo, J., Wang, J., Rong, X., Zhang, Q., Qin, Z., Hang, L., Feng, S., & Fan, X. (2019). Genetic analyses of oculocutaneous albinism types 1 and 2 with four novel mutations. BMC medical genetics, 20(1), 106. https://doi.org/10.1186/s12881-019-0842-7 

Okulicz, J. F., Shah, R. S., Schwartz, R. A., & Janniger, C. K. (2003). Oculocutaneous albinism. Journal of the European Academy of Dermatology and Venereology : JEADV, 17(3), 251–256. https://doi.org/10.1046/j.1468-3083.2003.00767.x 

Summers CG. Albinism: classification, clinical characteristics, and recent findings. Optom Vis Sci. 2009 Jun.  

Goldberg, R. A., Lally, D. R., & Heier, J. S. (2015). Oculocutaneous albinism. JAMA ophthalmology, 133(3), e143518. https://doi.org/10.1001/jamaophthalmol.2014.3518 

 

descargar

Detail description

Download



IGENOMIX_PartOfVitrolifeGroup_black

WE GUIDE YOU

Fertility
Inherited diseases prevention
Healthy pregnancy

OUR SERVICES

Genetic solutions
Learn about genetics
How to send a sample

ABOUT US

About Igenomix
Contact
Quality
Work with us

FOLLOW IGENOMIX

Blog: Path to fertility

  +91 11 4925 6000
  Write us
  • Brazil
  • Canada
  • Europe
  • India
  • Italy
  • Japan
  • Korea
  • Latam
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
Language

[2024] © Igenomix Privacy policy Quality policy Legal note Cookies policy




  • We guide you
    • Fertility
    • Inherited diseases
    • Worry-free pregnancy
  • Reproductive Health
    • Specialists
      • SAT
      • CGT
      • PGT-A
      • PGT-M
      • PGS+ERA Synchrony
      • Embrace
      • ERA
      • EMMA
      • ALICE
      • Endometrio
      • Family POC
    • Patients
      • SAT
      • CGT
      • PGT-A
      • PGT-M
      • PGS + ERA Synchrony
      • Embrace
      • ERA
      • EMMA
      • Family POC
      • ALICE
      • Endometrio
  • Diagnostic
  • About us
    • Igenomix Research
    • About Igenomix
  • ACADEMY
  • Language
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT